Table 1.
Sociodemographic and clinical characteristics at the time of presentation for delivery, stratified by SARS‐CoV‐2 RT‐PCR result and symptomatic status
|
SARS‐CoV‐2 RT‐PCR‐positive |
SARS‐CoV‐2 RT‐PCR‐negative |
P value | ||
|---|---|---|---|---|
| Symptomatic | Asymptomatic | |||
| n = 15 | n = 55 | n = 605 | ||
| Sociodemographics | ||||
| Age (years), median (IQR) | 30.5 (26.1–36.8) | 31.4 (26.6–37.2) | 34.0 (30.9–37.1) | 0.012 |
| Race, n (%) | ||||
| White | 4 (26.7) | 11 (20.0) | 235 (38.8) | <0.001 |
| Black | 2 (13.3) | 9 (16.4) | 25 (4.1) | |
| Asian | 2 (13.3) | 7 (12.7) | 196 (32.4) | |
| Unknown | 7 (46.7) | 28 (50.9) | 149 (24.6) | |
| Ethnicity, n (%) | ||||
| Hispanic | 4 (26.7) | 15 (27.3) | 50 (8.3) | <0.001 |
| Non‐Hispanic | 10 (66.7) | 23 (41.8) | 376 (62.1) | |
| Unknown | 1 (6.7) | 17 (30.9) | 179 (29.6) | |
| Insurance, n (%) | ||||
| Public | 7 (46.7) | 27 (49.1) | 157 (26.0) | <0.001 |
| Private | 8 (53.3) | 28 (50.9) | 448 (74.0) | |
| Site, n (%) | ||||
| NYP‐WCM | 6 (40.0) | 24 (43.6) | 304 (50.2) | 0.004 |
| NYP‐Queens | 7 (46.7) | 25 (45.5) | 151 (25.0) | |
| NYP‐LMH | 2 (13.3) | 6 (10.9) | 150 (24.8) | |
| Clinical characteristics | ||||
| Gravidity, median (IQR) | 2.0 (2.0–5.0) | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 0.18 |
| Parity, median (IQR) | 1.0 (0.0–2.0) | 0.0 (0.0–1.0) | 1.0 (0.0–1.0) | 0.25 |
| Gestational age on admission (weeks), median (IQR) | 38.7 (37.4–39.9) | 39.0 (37.6–39.6) | 39.1 (38.4–39.7) | 0.11 |
| Indications for admission, n (%) | ||||
| Labour indications | 7 (46.7) | 30 (54.5) | 262 (43.3) | <0.001 |
| Fetal indications | 1 (6.7) | 4 (7.3) | 26 (4.3) | |
| Scheduled delivery | 3 (20.0) | 13 (23.6) | 258 (42.6) | |
| COVID‐19‐like symptoms | 2 (13.3) | 0 (0.0) | 0 (0.0) | |
| Preterm labour or preterm premature rupture of membranes | 1 (6.7) | 2 (3.6) | 25 (4.1) | |
| Other | 1 (6.7) | 6 (10.9) | 34 (5.6) | |
| Comorbidities | ||||
| Chronic hypertension, n (%) | 3 (20.0) | 0 (0.0) | 13 (2.1) | 0.006 |
| Pre‐eclampsia or gestational hypertension, n (%) | 3 (20.0) | 8 (14.5) | 56 (9.3) | 0.14 |
| Pregestational diabetes mellitus, n (%) | 1 (6.7) | 3 (5.5) | 7 (1.2) | 0.021 |
| Gestational diabetes mellitus, n (%) | 3 (20.0) | 3 (5.5) | 54 (8.9) | 0.20 |
| Asthma, n (%) | 2 (13.3) | 4 (7.3) | 35 (5.8) | 0.26 |
| Pre‐pregnancy BMI ≥ 30 kg/m2 *, n (%) | 5 (83.3) | 7 (22.6) | 50 (14.5) | <0.001 |
| Smoking, n (%) | 1 (6.7) | 0 (0.0) | 4 (0.7) | 0.16 |
*
Data incompletely available for this variable because of incomplete capture of pre‐pregnancy BMI.